Hollister Biosciences Signs Definitive Agreement to Acquire Venom Extracts With $16.4 Million in Revenue and $2.48 Million EBITDA
This highly accretive acquisition will strengthen Hollister's brand portfolio and broaden its distribution across multiple statesVANCOUVER, March 6, 2020 - Holl... Read More...